Jpmorgan Chase & CO Simulations Plus, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 47,365 shares of SLP stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,365
Previous 22,994
105.99%
Holding current value
$1.48 Million
Previous $1.12 Million
35.72%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SLP
# of Institutions
176Shares Held
15.2MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$77.2 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$60.6 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$36 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$28.3 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$20.1 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $636M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...